Drag a card by its title · ⚙ to size, swap or remove
⠿
Who
SASusan E. Atkins
Director
Company insider
Files Form 4 as: Director, BioXcel Therapeutics.
⠿
In numbers
- Trades disclosed
- 2
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 12 Aug 2026
- Last trade
- 12 Aug 2026
- Last filed
- 14 Aug 2026
⠿
Companies traded
Everywhere else they filed: board seats, 10% stakes, other companiesBioXcel TherapeuticsDirector · Biotechnology · last 12 Aug 20260 buys · 0 sells
⠿
Activity over time
Not enough dated trades to draw.
⠿
Every trade
| Traded | Company | What | Amount | |
|---|
| 12 Aug 2026filed 14 Aug 2026 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
| 12 Aug 2026filed 14 Aug 2026 | BioXcel Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,000 at $0.00 | filing |
⠿
News
No headline names them, or the companies they trade most, lately.
⠿
Sectors
No trade we could place in a sector.
⠿
Related people
Frank YoccaChief Scientific Officer · Chief Scientific Officer at BioXcel Therapeutics, filing Form 4 there in the last year Vimal MehtaCEO and President · CEO and President at BioXcel Therapeutics, filing Form 4 there in the last year Richard I. SteinhartDirector · Chief Financial Officer at BioXcel Therapeutics, filing Form 4 there in the last year Javier RodriguezOfficer · Officer at BioXcel Therapeutics, filing Form 4 there in the last year